Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1163
-
Total 13F shares, excl. options
-
228M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$21.5B
-
Value change
-
+$236M
-
Put/Call ratio
-
0.47
-
Number of buys
-
443
-
Number of sells
-
-492
-
Price
-
$94.43
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2020
1,273 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2020.
NOVARTIS AG - Ordinary Shares (NVS) has 1,163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 228M shares
of 2.18B outstanding shares and own 10.44% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (21.8M shares), Dodge & Cox (21.6M shares), LOOMIS SAYLES & CO L P (20.1M shares), BANK OF AMERICA CORP /DE/ (9.81M shares), Fisher Asset Management, LLC (9.34M shares), FRANKLIN RESOURCES INC (8.52M shares), Aristotle Capital Management, LLC (7.12M shares), Mawer Investment Management Ltd. (6.63M shares), WELLS FARGO & COMPANY/MN (6.35M shares), and Boston Partners (6.05M shares).
This table shows the top 1163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.